🔗 Permalink

Inventor profile of:

Eric Brian Sjogren

City:

Mountain View, California

Country:

United States

Published Applications:

29

Last publication date:

2021-07-08

Top Assignees for applications by Eric Brian Sjogren

The entities that hold a legal rights for patent applications filed by inventor Sjogren Eric Brian:

Roche Palo Alto LLC 12 Palo Alto, CA United States
Roivant Sciences GmbH 4 Basel, Switzerland
CALITHERA BIOSCIENCES INC. 4 South San Francisco, CA United States
Karos Pharmaceuticals, Inc. 2 New Haven, CT United States
ALTAVANT SCIENCES GmbH 2 BASEL, Switzerland
Kanos Pharmaceuticals, Inc. 1 New Haven, CT United States
Roche Palo Alto LLC 1 San Francisco, CA United States
Roche Palo Alto LLC 1 Roche Palo Alto, CA United States
ROCHE PALO ALTO LLC 1 South San Francisco, CA United States
Syntex U.S.A. LLC 1 Palo Alto, CA United States
Hoffmann-La Roche Inc. 1 Nutley, NJ United States

Recent patent applications by Sjogren Eric Brian

Eric Brian Sjogren from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-07-08

US20210205305A1

Human necessities

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#2 | 2020-07-30

US20200237760A1

Human necessities

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#3 | 2019-09-19

US20190282575A1

Human necessities

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#4 | 2018-09-13

US20180256574A1

Human necessities

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#5 | 2018-04-05

US20180092918A1

Human necessities

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#6 | 2017-04-06

US20170095476A1

Human necessities

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#7 | 2016-04-07

US20160096836A1

Chemistry; metallurgy

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#8 | 2015-03-19

US20150080393A1

Chemistry; metallurgy

Spirocyclic compounds as tryptophan hydroxylase inhibitors

#9 | 2015-01-01

US20150004134A1

Chemistry; metallurgy

TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE

#10 | 2014-07-10

US20140194421A1

Chemistry; metallurgy

Heterocyclic glutaminase inhibitors

#11 | 2014-02-20

US20140050699A1

Chemistry; metallurgy

Heterocyclic inhibitors of glutaminase

#12 | 2013-06-20

US20130157998A1

Chemistry; metallurgy

Heterocyclic inhibitors of glutaminase

#13 | 2011-03-10

US20110059118A1

Chemistry; metallurgy

Inhibitors of JAK

#14 | 2010-01-28

US20100021423A1

Chemistry; metallurgy

Heterocyclic antiviral compounds

#15 | 2010-01-21

US20100016302A1

Chemistry; metallurgy

Inhibitors of Bruton's tyrosine kinase

#16 | 2010-01-21

US20100016301A1

Chemistry; metallurgy

Inhibitors of bruton's tyrosine kinase

#17 | 2010-01-07

US20100004231A1

Chemistry; metallurgy

Inhibitors of Burton's tyrosine kinase

#18 | 2009-10-29

US20090270389A1

Chemistry; metallurgy

Pyrimidinyl pyridone inhibitors of kinases

#19 | 2007-03-13

US10807993

Non-nucleoside reverse transcriptase inhibitors

#20 | 2006-11-09

US20060252784A1

Chemistry; metallurgy

Imidazo-substituted compounds as p38 kinase inhibitors

#21 | 2006-11-09

US20060252783A1

Chemistry; metallurgy

Imidazo-substituted compounds as p38 kinase inhibitors

#22 | 2005-12-27

US10066040

Pyrazole derivatives-p38 MAP kinase inhibitors

#23 | 2005-12-20

US10307130

Piperidine CCR-3 receptor antagonists

#24 | 2005-12-08

US20050272730A1

Chemistry; metallurgy

Thienopyridazines as IKK inhibitors

#25 | 2005-09-27

US10406364

Imidazo-substituted compounds as p38 kinase inhibitors

#26 | 2005-09-08

US20050197352A1

Chemistry; metallurgy

Imidazo-substituted compounds as p38 kinase inhibitors

#27 | 2005-06-14

US10307159

Piperazine CCR-3 receptor antagonists

#28 | 2005-05-19

US20050107403A1

Chemistry; metallurgy

Aminopyrimidine and aminopyridine anti-inflammation agents

#29 | 2005-01-25

US10288968

Aminopyrimidine and aminopyridine anti-inflammation agents

InventorID:

301092 ⎘